Language barrier means millions of elderly can't access Alzheimer's trials

Student voices

By | Josh Eibelman , NPR

in this NPR Op-Ed, Josh Eibelman '20 describes how millions of individuals suffering from Alzheimers that are not fluent in English are barred from participating in clinical trials to treat Alzheimers. 

"According to interviews with doctors, government officials and pharmaceutical companies, few Alzheimer's studies include medical interpreters to help patients complete the specialized neuropsychological testing component required," Eibelman writes. 

Continue reading the full article on the NPR website. 

More News from A&S

Five people stand near a sign that says "Center on Global Democracy"
Provided Center on Global Democracy

Cornell scholars address global threats to democratic institutions

Government
Cornell Chronicle
Person sitting high in a tree, reading a book with a large college building in the background
Sreang Hok/Cornell University. Early spring reading on the Arts Quad

Your March 2025 reads

Alumni authors
Cornellians
Car driving past a factory belching smoke
Olga Subach/Unsplash Newark, New Jersey

Cornell expert: EPA regulations rollback
 will reduce quality of life

Government
A&S Communications
Two people cutting a red ribbon ceremonially. They are outdoors
Provided Officially launching the Abruña Energy Initiative Level 3 electric vehicle fast-charging station: Interim President Michael Kotlikoff (left) and Héctor D. Abruña, the Émile M. Chamot Professor of Chemistry in the Department of Chemistry and Chemical Biology.

First Level 3 EV fast-charging station opens on campus

Chemistry and Chemical Biology
Cornell Chronicle
View all news
Students performing clinical research.